










































































































































































































































































































































































Erosions   Joint space narrowing 
0 – Normal  0 – Normal 
1 – Discreet erosions 1 – Focal narrowing 
2 – 3 – Larger erosions according to surface area 
affected 
2 – Reduction of less than 50% joint space 
4 – Erosion extending over middle of bone 3 - Reduction of greater than 50% joint space 




0 Intact bony outlines and normal joint space 
1 Erosion less than 1 mm in diameter or joint space narrowing 
2 One or several small erosions, diameter more than 1 mm 
3 One or several small erosions, diameter more than 1 mm, on both sides of the joint 
4 Severe erosions, where there is usually no joint space left, and the original bony outlines 
are partly preserved or subluxation 

























































































































































































































































































































SENS score distribution Reader 2
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Larsen score distribution Reader 1
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SENS score distribution Reader 1
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Larsen score distribution Reader 2
0 10 20 30 40 50 60 70 80



































































Variable	 Coefficient	 95%	CI	 P-value	
Disease	duration	 0.04	 -0.022	–	0.109	 0.190	
Smoking		 0.21	 -0.663	–	1.086	 0.633	
aRF	(>14)	 -0.46	 -2.58	–	1.66	 0.668	
bACCP	 0.00	 -0.001	–	0.002	 0.511	
cCDAI	 -0.01	 -0.037	–	0.016	 0.440	
dTJC	 -0.05	 -.0114	–	0.010	 0.102	
eSJC	 -0.06	 -.0137	–	0.021	 0.147	
fPGA	 -0.01	 -0.029	–	0.003	 0.100	
gPhGA	 0.00	 -0.019	–	0.016	 0.888	
28	
hSDAI	 -0.01	 -0.032	–	0.018	 0.597	
iCRP	 0.0113	 0.010	–	0.022	 0.032	
jESR	 0.01	 -.0004	–	0.024	 0.176	









Variable	 Coefficient	 95%	CI	 P-value	
Disease	duration	 0.02	 -0.020	–	0.063	 0.304	
Smoking		 0.20	 -0.349	–	0.748	 0.473	
aRF	(>14)	 -0.40	 -1.728	–	0.928	 0.551	
bACCP	 0.00	 -0.001	–	0.001	 0.670	
cCDAI	 0.00	 -0.019	–	0.015	 0.810	
dTJC	 -0.02	 -0.062	–	0.017	 0.261	
eSJC	 -0.02	 -0.068	–	0.032	 0.479	
fPGA	 0.00	 -0.008	–	0.014	 0.627	
gPhGA	 -0.01	 -0.017	–	0.002	 0.134	
hSDAI	 0.00	 -0.016	–	0.015	 0.978	
iCRP	 0.008	 0.002	–	0.149	 0.007	
jESR	 0.01	 -0.001	–	0.016	 0.071	















































































Fex	(1996)	 HAQ	vs	Larsen	 Spearman’s	correlation	 0.11	(>0.005)	
Mottonen	(1998)	 HAQ	vs	Larsen	 Spearman’s	correlation	 -0.03	(>0.05)	
Gordon	(2001)	 HAQ	vs	Larsen	 Spearman’s	correlation	 0.465	(0.001)	
Plant	(2005)	 HAQ	vs	modified	Larsen	 Spearman’s	correlation	 -0.06	(>0.05)	
Daya	2016	 HAQ	vs	modified	Larsen	
HAQ	vs	SENS	
Spearman’s	correlation	 -0.168	(>0.05)	
-0.101	(>0.05)	
aHAQ	–	Health	assessment	questionnaire;	
Table	4.1.	adapted	from	Bombardier	et	al	(Bombardier	et	al.,	2012)	
	
Scott	et	al	(Scott	et	al.,	2003)	explain	that	there	is	either	a	weak	or	no	correlation	
between	radiographic	damage	and	disability	in	early	RA.	This	is	explained	by	the	J-shaped	
curve	of	disease	duration	and	functional	disability.	High	levels	of	disability	in	early	disease	
tend	to	improve	on	treatment	and	when	inflammation	is	decreased.	As	disease	
progresses,	the	HAQ	increases	as	irreversible	joint	damage	results	in	permanent	disability	
(Bombardier	et	al.,	2012).	Multiple	previous	studies	showed	that	radiographic	damage	
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exerts	a	significant	effect	on	functional	disability	but	only	after	6	to	12	years	(Scott	et	al.,	
2000)	(Welsing	et	al.,	2001)	(Ory,	2003).	Another	explanation	for	the	disconcordance	
between	the	HAQ	score	and	radiographic	damage	may	be	that	HAQ	may	cause	large	joint	
dysfunction,	while	both	the	Larsen	and	SENS	scores	evaluate	only	small	joints.	In	this	
study,	only	small	joints	were	evaluated.	
	
Disease	activity	has	long	been	known	to	be	an	important	outcome	and	therapeutic	target	
in	RA	trials	as	well	as	in	clinical	practice.	This	is	because	it	plays	a	central	role	in	the	
relationship	between	disease	activity,	joint	damage	and	functional	impairment	(Aletaha	
and	Smolen,	2009)	by	virtue	of	the	fact	that	it	causes	joint	damage	which	eventually	
results	in	loss	of	function.	This	study	was	cross-sectional	at	the	time	of	diagnosis,	prior	to	
any	therapy	being	instituted.	The	correlation	between	disease	activity	(as	measured	by	
CDAI	and	SDAI)	and	radiographic	damage	was	not	significant,	however	there	was	a	
significant	correlation	between	acute	phase	reactants	(CRP	and	ESR)	with	radiographic	
scores.	Previous	studies	have	demonstrated	that	there	is	a	positive	correlation	(r=	0.59	
for	CDAI,	p-value	<0.0001)	(Anderson	et	al.,	2011),	(CDAI	r=0.59	and	SDAI	r=0.54)	(Aletaha	
et	al.,	2005)	however	these	studies	were	longitudinal,	assessing	the	relationship	between	
change	in	disease	activity	relative	to	change	in	radiographic	score,	thus	using	time	
averaged	values.	It	has	been	previously	demonstrated	that	the	radiographic	progression	
in	patients	with	early	RA	is	not	linear,	and	that	fluctuation	in	disease	activity	were	
associated	with	joint	damage,	but	that	this	is	a	longitudinal	relationship	(Welsing	et	al.,	
2004).	This	highlights	the	need	to	monitor	disease	activity	closely	in	patients	with	RA	to	
guide	therapy	options,	with	the	end	goal	of	achieving	remission.	
	
34	
Earlier	studies	found	that	radiographic	damage	is	a	result	of	the	additive	effects	of	the	
disease	prior	to	the	current	measure	of	disease	activity.	This	study	(van	Leeuwen	et	al.,	
1997)	showed	that	inflammatory	markers	CRP	and	ESR	are	closely	correlated	with	
radiographic	damage.	Subsequent	work	(Aletaha	et	al.,	2005)	has	shown	that	acute	phase	
reactants	are	not	significantly	contributory	to	disease	activity	scores.	
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4.2.	Limitations	of	the	current	study	
A	limitation	of	our	study	is	that	neither	of	the	readers	are	experienced	nor	formally	
trained	musculoskeletal	radiologists.	There	was	also	no	formal	training	of	the	readers	by	a	
musculoskeletal	radiologist.	The	limited	training	was	online,	through	a	teaching	website	
from	the	University	of	Sherbrooke,	Canada	
(http://rheumatology.usherbrooke.ca/?q=scoresharp#section_3).			
	
There	was	an	agreed	acceptable	variance	(<10%)	between	the	readers	for	each	patients’	
Larsen	and	SENS	scores,	as	a	result,	second	read	consensus	agreements	for	32	(33,7%)	
patients	was	performed.	The	importance	of	a	limited	variance	is	that	the	statistical	
analysis	between	radiographic	scores	and	secondary	variables	assessed	in	the	study	(HAQ,	
CDAI,	SDAI,	CRP	&	ESR)	is	more	reliable	and	not	swayed	by	incorrect	radiographic	scores.	
The	limitation	of	this	decision	is	that	the	agreement	between	scores	of	reader	1	and	2	are	
skewed.	
The	cross	sectional	nature	of	this	study	also	limits	the	conclusions	that	one	can	
extrapolate	between	radiographic	damage,	disease	activity	and	functional	disability.	
Future	prospective	studies,	also	evaluating	patients	on	treatment	for	RA	can	follow	this	
South	African	cohort	of	patients	to	see	if	the	relationship	between	radiographic	damage	is	
similar	to	study	populations	globally.	
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4.3.	Future	applications		
The	current	study	utilised	two	radiologists	to	score	the	radiographs.	A	potential	future	
application	would	be	to	perform	a	similar	study	using	a	rheumatologist	and	a	radiologist.	
The	rheumatologist	would	benefit	in	every	day	practice,	by	using	radiographic	scores	to	
have	an	immediate	idea	of	patients’	disease	progression,	thus	guiding	treatment.	The	
rheumatologist	also	has	a	good	understanding	of	each	particular	patient’s	background	as	
well	as	clinical	examination	findings.	This	may	result	in	him	focusing	on	particular	joints	
when	assessing	radiographs.	Radiographic	damage	scoring	can	be	performed	by	either	
the	rheumatologists	or	the	radiologists.	The	marked	staff	shortage	at	CHBAH	means	that	
plain	film	radiographs	of	patients	attending	the	arthritis	clinics	are	not	reported,	let	alone	
scored	for	radiographic	damage.	These	X-rays	are	interpreted	by	the	attending	physician	
or	rheumatologist	in	the	clinics.	Ideally,	collaboration	between	the	radiology	and	
rheumatology	department	should	be	set	up	to	facilitate	training	for	radiographic	scoring	
for	both	specialities.	The	benefits	of	this	would	be	twofold:	patient	management	would	
be	improved	and	teaching	of	trainee	rheumatology	and	radiology	doctors	to	enhance	
their	skills.		
	
4.4.	Conclusion	
This	aim	of	this	study	was	to	score	radiographic	damage	in	early	rheumatoid	arthritis	
using	two	scoring	systems.	We	have	demonstrated	that	there	is	strong	agreement	
between	the	Larsen	and	SENS	methods,	and	that	these	systems	are	useful	in	early	RA	
disease.	The	relatively	simple	nature	of	performing	these	scores	means	that	they	can	be	
performed	in	everyday	clinical	practice	with	minimal	formal	training,	as	a	means	to	gauge	
disease	severity	and	to	guide	future	management.		
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There	is	no	significant	correlation	between	the	radiographic	scores	and	disease	activity	
scores,	however	the	inflammatory	markers	(which	make	up	a	part	of	the	disease	activity	
scores)	are	statistically	correlated	to	both	the	SENS	and	modified	Larsen	scores.		
	
There	is	no	correlation	between	functional	disability	and	radiographic	damage	scores	of	
patients	with	early	RA.	Continued	longitudinal	radiographic	monitoring	is	of	more	value	
than	a	single	evaluation	of	joint	damage	at	initial	presentation	to	the	health	care	
provider.			
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